FDx Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,575
| Closed | -$206K | – | 848 |
|
|
2022
Q1 | $206K | Buy |
+5,575
| New | +$206K | 0.01% | 788 |
|
|
2021
Q4 | – | Sell |
-7,507
| Closed | -$252K | – | 867 |
|
|
2021
Q3 | $252K | Sell |
7,507
-869
| -10% | -$29.2K | 0.01% | 718 |
|
|
2021
Q2 | $334K | Buy |
8,376
+658
| +9% | +$26.2K | 0.01% | 625 |
|
|
2021
Q1 | $347K | Buy |
7,718
+534
| +7% | +$24K | 0.01% | 582 |
|
|
2020
Q4 | $406K | Buy |
7,184
+1,024
| +17% | +$57.9K | 0.02% | 490 |
|
|
2020
Q3 | $292K | Buy |
6,160
+685
| +13% | +$32.5K | 0.01% | 492 |
|
|
2020
Q2 | $323K | Sell |
5,475
-252
| -4% | -$14.9K | 0.02% | 431 |
|
|
2020
Q1 | $271K | Sell |
5,727
-696
| -11% | -$32.9K | 0.02% | 410 |
|
|
2019
Q4 | $388K | Buy |
6,423
+287
| +5% | +$17.3K | 0.02% | 417 |
|
|
2019
Q3 | $368K | Buy |
6,136
+351
| +6% | +$21.1K | 0.03% | 423 |
|
|
2019
Q2 | $372K | Buy |
5,785
+1,269
| +28% | +$81.6K | 0.01% | 561 |
|
|
2019
Q1 | $367K | Sell |
4,516
-1,013
| -18% | -$82.3K | 0.01% | 543 |
|
|
2018
Q4 | $299K | Sell |
5,529
-676
| -11% | -$36.6K | 0.02% | 413 |
|
|
2018
Q3 | $320K | Sell |
6,205
-119
| -2% | -$6.14K | 0.01% | 673 |
|
|
2018
Q2 | $264K | Buy |
6,324
+760
| +14% | +$31.7K | 0.01% | 767 |
|
|
2018
Q1 | $245K | Sell |
5,564
-138
| -2% | -$6.08K | 0.01% | 1061 |
|
|
2017
Q4 | $287K | Buy |
5,702
+262
| +5% | +$13.2K | 0.01% | 1059 |
|
|
2017
Q3 | $276K | Buy |
5,440
+168
| +3% | +$8.52K | 0.01% | 1080 |
|
|
2017
Q2 | $268K | Buy |
+5,272
| New | +$268K | 0.01% | 1022 |
|